Health technology assessment in Europe. Improving clarity and performance.
This paper discusses the challenges facing health technology assessment (HTA) in Europe, based on an explicit analysis of the characteristics of an "optimal" HTA system. It has three objectives: a) to elaborate an explicit system of policy goals and the characteristics of an optimal HTA system that facilitates the achievement of these goals; b) to identify the general institutional incentive barriers (government and market failures) that prevent the attainment of an optimal HTA system in Europe; and c) to argue that evaluation of the implications of health technologies for equity and inequality in health is an essential part of this optimal system and a considerable challenge for HTA decision makers, especially as national governments realign policy toward equity goals.
London School of Economics.
R
R
Cookson
A
A
Maynard
D005060:Europe; D019317:Evidence-Based Medicine; D006291:Health Policy; D006297:Health Services Accessibility; D009937:Organizational Objectives; D011785:Quality Assurance, Health Care; D012935:Social Justice; D013673:Technology Assessment, Biomedical / Q000458:organization & administration* / Q000592:standards